Spending After Sacubitril-Valsartan vs Renin-Angiotensin System Blockers for Heart Failure

This cohort study assesses health care costs after initiating sacubitril-valsartan compared to an angiotensin-converting enzyme inhibitor or an angiotensin II receptor-blocker in Medicare patients being treated for heart failure with reduced ejection fraction.

from JAMA Health Forum New Online https://ift.tt/kLa5Wd8